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Adverse effectsAbstract The elderly population is increasing throughout the globe, resulting in higher healthcare
costs. Potential inappropriate medication (PIM) prescriptions are a major health problem affecting
the elderly persons. Due to limited studies in PIM use in primary care and home healthcare in Saudi
Arabia, we aim to examine the extent of PIM prescription for and use by elderly patients. This study
was carried out with 798 elderly patients, arbitrarily selected from Prince Sultan Medical Military
City through the patient register. The mean age of the patients were in the range of 75.2 ± 5.5;
37.8% were males and 62.2% were females. The elderly patients are affected majorly with diabetes
(73.9%), hypertension (83.2%) and lipid abnormalities (73.8%). The maximum patients involved in
this study were affected with lower hemoglobin levels i.e. 99.2%. Renal impairment was found in
64% and iron supplements were the most commonly used in 23.1%, followed by analgesics and opi-
oids (17%). The 52.5% of participants were using one or more PIMs. Kidney was the only functions
and had influence on prescribed decisions. This study indicates PIM is a concern in elderly patients
attending clinics and home residents and commonly prescribed ones are atypical antipsychotics,
iron overdose, benzodiazepines and opioids. Prescription of drug–drug interactions, cascades and
inappropriate drug doses results in preventable adverse effects.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The elderly population is increasing globally, resulting in
higher healthcare costs and demand for services (Klarin
et al., 2005; Fick et al., 2001). The estimation of current statis-
tics suggests that 2.9% of the affected elderly persons were
more than 65 years of age in the Saudi population (WHO,
2011). One of the challenges in the provision of healthcare to
elderly persons is inappropriate prescriptions, drug-related is
inappropriate prescriptions and complications. The earlier
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more than 65 years of age consumed at least 10 medications at
any given time, and five prescription drugs monthly (Kaufman
et al., 2002). One of the study from European population
showed that the older people in community-dwelling received
2.8–5.0 drugs (Brekke et al., 2008). An earlier study in the
90s concluded the person who receives two, four and seven
drugs experienced with 13%, 38% and 82% risk (Goldberg
et al., 1996). Duplicate use of drugs within the same class is
common and often unrecognised. The side effects of drugs
are leading to polypharmacy, coupled with continued prescrip-
tion of cascades (example; prescribing levodopa for parkinso-
nian symptoms resulting from neuroleptic drugs side effects)
(Col et al., 1990). Older individuals are at a higher risk of
developing drug-related adverse events because of age-related
changes and reduced organ reserve capacity (Byles et al.,
2003). Furthermore, age-related changes in drug pharmacoki-
netics and pharmacodynamics and coexisting diverse underly-
ing medical morbidities contribute towards serious adverse
drug interaction and toxicity (Handler et al., 2006). Polyphar-
macy, non-prescription drugs and inadequate treatment adher-
ence carry a substantially high risk for morbidity and
mortality. Hospital admission, functional impairment, falls,
cognitive decline, drug toxicity and poor quality of life are
common, due to inappropriate prescription of medication
(Williams, 2002; Chin et al., 1999; Buajordet et al., 2001). In
total, 5% of total hospitalisations are reportedly drug-
related; 17% thereof are of older adults (Lazarou et al., 1998).
Drug-related problems are common in primary care (Doshi
et al., 2005) and up to 35% of older patients attending outpa-
tient clinics develop preventable adverse drug interactions
(Mallet et al., 2007). Prescription of inappropriate medications
is an important preventable drug-related problem (Beijer and
de Blaey, 2002). A potentially inappropriate medication
(PIM) refers to prescription of drugs carrying risks outweigh-
ing the expected clinical benefits, especially when there is evi-
dence for an equally or more effective and safer alternative
medication (Spinewine et al., 2007; Chang and Chan, 2010).
There are few international evidence-based studies on a com-
prehensive clinical approach comprising appropriate drug pre-
scription for elderly people. Beers’ criteria, published in 1991
and updated in 2003 and 2012 (Beers et al., 1991; Fick and
Semla, 2012; Fick et al., 2003), are the most widely used tool
for appropriate prescription and monitoring of elderly persons
in ambulatory settings and long-term facilities. Recently,
Beers’ criteria updated PIMs to include up to 53 drugs in three
classes, which may carry negative outcomes and limited effec-
tiveness for elderly people. The criteria had been well described
and emphasised, to improve the care of older adults and
reduce exposure to PIMs (Fick and Semla, 2012). PIMs fall
under three major therapeutic classes, organs and systems,
namely: PIMs and classes to avoid in older adults, PIMs and
classes to avoid in older adults with certain diseases and syn-
dromes and medications to be used with caution in older
adults.
There is insufficient evidence regarding PIM use in primary
care and home healthcare in Saudi Arabia. One economic-
focused, cross-sectional study, conducted from 2002 to 2004,
at Riyadh Military Hospital, using outpatients’ pharmacy-
dispensary records, found that 43.6%, 18% and 38.4% of
patients took at least one, two and three or more PIMs, respec-
tively (Al-Omar et al., 2012). Since there are limited qualitativeand quantitative data locally on appropriate drug use among
elderly persons, in ambulatory settings and home healthcare,
the majority of prescriptions are by family physicians; improv-
ing the quality of family physicians’ prescriptions would
improve patients’ quality of life and minimise drug hazards.
Hence, we conducted this study, to identify and analyse the
medications taken by elderly persons consulting family physi-
cians at the Family and Community Medicine and the Home
Healthcare departments at Prince Sultan Military Medical
City, Riyadh, and to classify the dispensed drugs, based on
Beers’ criteria, as PIMs.
This study aimed to establish the extent of inappropriate
drug prescription for and use by elderly patients, by determin-
ing the proportion of: (1) ambulatory medical care visits by
elderly patients resulting in inappropriate drug prescription
(visit-level analysis), and (2) elderly, community-dwelling
recipients of inappropriate drugs (person-level analysis). Sec-
ondly, the study examined trends in these outcomes for recent
years and, thirdly, factors associated with a higher risk of inap-
propriate drug prescription/use.2. Materials and methods
The target population was elderly patients, aged P65 years,
despite gender and ethnicity. Common medical co-
morbidities possibly influencing the number of medications
and pharmacokinetics, and the number of medications used
by the elderly, were recorded. Only Prince Sultan Medical Mil-
itary City (PSMMC) items and non-over–the-counter (non-
OTC) medications were counted and registered for each
patient. Non-PMMSC items, OTC medication and herbal sup-
plements were excluded from the analysis, as they were not
well recorded for each patient. We pooled and documented
laboratory results possibly indicating functional impairment
of common organs (renal function, liver function, uncontrolled
diabetes, etc.) and increasing the potential hazards of some
medications for each patient.
Data were collected from patients’ medical electronic and
non-electronic records, and from the main hospital laboratory
framework. Data were captured and managed on EXCEL.
Demographic data, a list of commonly used medications,
comorbidities, laboratory data sheets and prescribed medica-
tion multiplicity were prepared and used by investigators.
All registered elderly patients who visited family medicine
chronic disease clinics (CDCs) and those involved in the Home
Health Care (HHC) programme were included in this study;
institutionalised patients were excluded. 798n patients were
randomly selected through the patient registry programme,
from the data registries at Wazarat Family Medicine Center
and Home Health clinics. We excluded patients attending
other hospitals, with multiple medication prescriptions.
2.1. Statistical analysis
Data were analysed using an SPSS software programme (ver-
sion 20). Both descriptive and analytic statistics were applied.
Percentages, mean and standard deviation were used for
descriptive statistics. For analytical statistics, Chi squared test
was applied for categorical data, and Student’s t test and
ANOVA were applied for numerical data. Statistical signifi-
cance was considered at p< 0.05. The intended sample size
Figure 1 Participants’ medical conditions.
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use in clinical practice; they are the best-known criteria for
identifying PIM use among the elderly (Nagendra Vishwas
et al., 2012). Evidence-based methodology enabled the devel-
opment of the AGS 2012 Updated Beers’ Criteria, to help
healthcare providers improve medication safety in older
adults. To determine the number of PIMs, we applied the latest
criteria by Beers et al., published in 2012, and a review of sci-
entific literature. Apart from explaining the drugs and doses to
be avoided among elderly persons, to prevent adverse effects,
these criteria evaluate the severity of potential adverse effects.
We did not record treatment duration and indication of any
inappropriate prescribed drugs, due to difficulties with data
documentation.
3. Results
The study participants were elderly, as defined by the World
Health Organisation (WHO). The mean age was 75 years; with
SD (75.2 ± 5.5) with no significant differences between CDC
and HHC patients after using chi-square test. Female patients
made up 62.2% of the sample. Table 1 and Fig. 1 depict com-
mon chronic diseases among elderly participants. The majority
of patients were diabetic (73.9%), hypertensive (83.2%) and
with lipid profile abnormalities (73.8%). Almost all partici-
pants had haemoglobin abnormalities (99.2%), with no signif-
icant difference between CDC and HHCS patients. About
64% had some renal impairment.
Table 2 and Fig. 2 depict the medication groups used by the
patients. Iron supplements were the most commonly used
(23.1%), followed by analgesics and opioids (17%). Different
types of antipsychotics were used by 7.6% of the participants.
Some patients were using two types of analgesic drugs (2%);
few (0.1%) were using three types. Some patients (1%) were
using two kinds of antipsychotics simultaneously.Table 1 Age, sex and medical history of homecare and CDC patie
Total (n= 798) Homecare
No. % No.
Age
Mean ± SD 75.2 ± 5.5 75.8 ± 5.4
Median (Q1–Q3) 75 (71–79) 76 (72–80
Gender
Male 302 37.8 238
Female 496 62.2 425
Disorders
Diabetes type 2 (DM2) 590 73.9 458
Hypertension (HTN) 664 83.2 552
Dyslipidaemia 589 73.8 467
Ischaemic heart disease (IHD) 136 17.0 121
Congestive heart failure (CHF) 31 3.9 22
Dementia 50 6.3 49
Parkinson’s disease 37 4.6 36
Seizure disorders 37 4.6 37
Psychiatric diseases 193 24.2 188
Renal function test abnormality 511 64.0 417
Liver function test abnormality 5 0.6 3
Haemoglobin (Hb) abnormality 792 99.2 657
* Statistically significant at p< 0.05.Almost 52.5% of participants were using one or more PIMs
as in Table 3. At least 17.3% were using two; the majority were
using <4. One patient was using 10 PIMs simultaneously and
another using 12.
Antispasmodics and muscle relaxants, tolterodine and
chlorpheniramine, were frequently prescribed to 13 and 11
HHC patients respectively while two CDC patients were found
to take tolterodine. Risperidone was one of the atypical
antipsychotic medications prescribed to 39 HHC patients,
and quetiapine to 29. Only one CDC patient was taking queti-
apine. Other commonly prescribed medications were iron sup-
plements (ferrous sulphate for 184 patients), oral muscle
relaxants for 40 patients, hypoglycaemic (glibenclamide) for
49, diclofenac for 42 and tizanidine for 40. The most common
PIM was a high dose of ferrous sulphate, in about 33% of the
participants compared to the rest of the group (p< 0.001).
There was no statistical difference between the two patientnts.
(n= 663) CDC (n= 135) v2 test p-Value
% No. %
72.2 ± 5.0 t= 7.067 <0.001*
) 72 (68–76)
35.9 64 47.4
64.1 71 52.6 6.317 0.012*
69.1 132 97.8 47.933 <0.001*
83.3 112 83.0 0.007 0.933
70.4 122 90.4 23.053 <0.001*
18.3 15 11.1 4.044 0.044*
3.3 9 6.7 3.368 0.066
7.4 1 0.7 8.445 0.004*
5.4 1 0.7 5.578 0.018*
5.6 0 0.0 7.900 0.005*
28.4 5 3.7 37.175 <0.001*
62.9 94 80.3 13.397 <0.001*
0.2 2 1.5 Fisher 0.200
99.1 135 100.0 1.231 0.267
Table 2 Frequency of use of PIMs by medication group
(n= 798).
Frequency Percentage
Anticholinergics/muscle relaxants/antispasmodics
1 39 4.9
Antipsychotics
1 61 7.6
2 8 1
Antiepileptics
1 0 0.0
Sedative-hypnotics
1 6 0.8
Antihypertensives
1 12 1.5
Antidepressants
1 17 2.1
Skeletal muscle relaxants
1 43 5.4
Anti-infectives
1 2 0.3
Oral hypoglycaemics
1 49 6.1
Analgesics and opioids
1 119 14.9
2 16 2
3 1 0.1
Platelet aggregation inhibitors
1 4 0.5
Antiarrhythmics
1 7 0.9
Iron supplements
1 184 23.1
Table 3 Total number of PIMs among participants
(n= 798).
Total No. of medications Frequency Percentage
0 379 47.5
1 103 12.9
2 138 17.3
3 54 6.8
4 69 8.6
5 23 2.9
6 17 2.1
7 3 0.4
8 9 1.1
9 1 0.1
10 1 0.1
12 1 0.1
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Table 4).
As in Table 5, and based on Mann–Whitney U test results,
liver function had no significant influence on prescription deci-Figure 2 High-risk medicatisions. Only kidney function profile had some influence. Twelve
PIMs were prescribed to patients, without adjustment of their
renal impairment profile. Analgesics and opioids were the most
common PIMs for patients with renal insufficiency. There was
a statistically significant difference regarding prescription of
iron supplements, between patients with normal kidney func-
tion and those with renal impairment.
4. Discussion
Optimal drug therapy is essential in caring for elderly persons;
worldwide, elderly patients use medication. A safe prescription
method for elderly persons must include the decision as to
whether a drug is indicated, choosing the best drug, determin-
ing a dose and schedule appropriate for the patient’s physio-
logic status, monitoring for effectiveness and toxicity,
educating the patient about expected side effects, and indica-
tions for seeking consultation. Polypharmacy and inappropri-ons used by participants.
Table 4 Comparison of homecare and CDC patients’ medication use.
HHC (n= 663) CDC (n= 135) v2 test p-Value
1 2
Anticholinergic muscle relaxants
Oxybutynin 8 1.2 0 0.0 Fisher 0.364
Tolterodine 13 2.0 0 0.0 Fisher 0.141
Chlorpheniramine 11 1.7 0 0.0 Fisher 0.227
Hydroxyzine 2 0.3 0 0.0 Fisher 1.000
Hyoscyamine 1 0.2 0 0.0 Fisher 1.000
Scopolamine 2 0.3 2 1.5 Fisher 0.135
Antipsychotics
Quetiapine 29 4.4 1 0.7 4.092 0.043*
Haloperidol 5 0.8 0 0.0 Fisher 0.596
Olanzapine 3 0.5 0 0.0 Fisher 1.000
Risperidone 39 5.9 0 0.0 8.349 0.004*
Sedative-hypnotics
Diazepam 3 0.5 0 0.0 Fisher 1.000
Lorazepam 3 0.5 0 0.0 Fisher 1.000
Antihypertensives:
Methyldopa 1 0.2 1 0.7 Fisher 0.310
Spironolactone > 25 mg 9 1.4 1 0.7 Fisher 1.000
Antidepressants
Fluoxetine 4 0.6 0 0.0 Fisher 1.000
Clomipramine 1 0.2 0 0.0 Fisher 1.000
Amitriptyline 11 1.7 1 0.7 Fisher 0.702
Skeletal muscle relaxants
Tizanidine 38 5.7 2 1.5 4.255 0.039*
Baclofen 3 0.5 0 0.0 Fisher 1.000
Anti-infectives
Nitrofurantoin 2 0.3 0 0.0 Fisher 1.000
Oral hypoglycaemics
Glibenclamide 42 6.3 7 5.2 0.257 0.612
Analgesics and opioids
Ibuprofen 10 1.5 2 1.5 Fisher 1.000
Diclofenac 36 5.4 6 4.4 0.218 0.640
Paracetamol combination 80 12.1 18 13.3 0.167 0.683
Decongestant 2 0.3 0 0.0 Fisher 1.000
Platelet aggregation inhibitors
Dipyridamole 4 0.6 0 0.0 Fisher 1.000
Antiarrhythmics
Digoxin > 125 mcg 7 1.1 0 0.0 Fisher 0.609
Iron supplements
Ferrous sulphate > 325 mg 175 26.4 9 6.7 24.607 <0.001*
* Statistically significant at p< 0.05.
204 A. Al Odhayani et al.ately prescribed drugs cause many adverse events and, some-
times, are life threatening. Side effects are serious consequences
of inappropriate prescriptions. In our study, 52.5% of the 798
elderly, CDC and homecare patients were onP1 PIMs, as per
Beers’ criteria. One to two and five or more PIMs were pre-
scribed to approximately 30% and 6.8% of the participants,
respectively. We found less prevalence of PIMs among elderly
persons in this context in Saudi Arabia, than in some Western
countries (Hepler and Segal, 2003; Qato et al., 2008; Herings
et al., 1995; Ay et al., 2005; Rajska-Neumann and
Wieczorowska-Tobis, 2007).The most common PIM was a high dose of ferrous sulphate
(>325 mg/day) among about 33% of the participants. This is
due to the high prevalence of iron deficiency anaemia among
the elderly. High dose of iron supplement may precipitate con-
stipation, which in turn may induce abdominal pain, loss of
appetite, frequent falls and social isolation. High iron doses
were prescribed to 23% of surveyed patients, for no clear rea-
son. This is problematic and predisposes participants to seri-
ous side effects. Analgesics and opioids were the second most
prescribed medications, with P1 type thereof taken by
approximately 17%. According to previous studies, elderly
Table 5 Comparison of the number of PIM groups used, based on renal function tests (RFT).
Normal Renal Function Test (n = 269) Abnormal Renal Function Test (n = 511) Mann–Whitney (z) p
Mean SD Min Max Median Q1 Q3 Mean SD Min Max Median Q1 Q3
Anticholinergics/muscle relaxants/antispasmodics 0.1 0.2 0 1 0 0 0 0.0 0.2 0 1 0 0 0 1.226 0.220
Antipsychotics 0.1 0.4 0 2 0 0 0 0.1 0.3 0 2 0 0 0 1.680 0.093
Sedative-hypnotics 0.0 0.1 0 1 0 0 0 0.0 0.1 0 1 0 0 0 0.802 0.423
Antihypertensives 0.0 0.1 0 1 0 0 0 0.0 0.1 0 1 0 0 0 0.527 0.598
Antidepressants 0.0 0.1 0 1 0 0 0 0.0 0.1 0 1 0 0 0 0.071 0.944
Skeletal muscle relaxants 0.1 0.2 0 1 0 0 0 0.1 0.2 0 1 0 0 0 0.056 0.955
Anti-infectives 0.0 0.0 0 0 0 0 0 0.0 0.1 0 1 0 0 0 1.027 0.305
Oral hypoglycaemics 0.0 0.2 0 1 0 0 0 0.1 0.3 0 1 0 0 0 1.520 0.129
Analgesics and opioids 0.2 0.5 0 2 0 0 0 0.2 0.5 0 3 0 0 0 1.139 0.255
Platelet aggregation–inhibitors 0.0 0.1 0 1 0 0 0 0.0 0.0 0 1 0 0 0 1.708 0.088
Antiarrhythmics 0.0 0.1 0 1 0 0 0 0.0 0.1 0 1 0 0 0 1.266 0.206
Iron supplements 0.4 0.5 0 1 0 0 1 0.2 0.4 0 1 0 0 0 6.909 <0.001*
Total No. medications 1.7 2.0 0 10 1 0 3 1.3 1.8 0 12 0 0 2 3.209 0.001*
* Statistically significant at p< 0.05.
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206 A. Al Odhayani et al.patients require more analgesic prescriptions than do non-
clinical adult populations (Pitkala et al., 2002). This could be
because elderly persons experience multiple medical problems
and pain, due to chronic diseases like osteoarthritis, muscular
pain, headaches and joint pains. Sometimes, a physician may
not have sufficient skills to care for elderly patients or time
to scrutinise patient history and physical examination, to
determine the exact medical problem.
In this study, antipsychotic medications were the third most
commonly prescribed drugs (8.6%). Despite the strong recom-
mendation against prescription of antipsychotics to older
patients, unless necessary, more than 69 patients received P1
thereof. Anti-psychotic medications reportedly predispose
elderly patients to falls, fractures, sleep problems and driving
problems (AGSP, 2009). Scientific geriatric organisations warn
physicians against prescribing antipsychotic drugs to elderly
persons for periods exceeding four weeks, to avoid serious side
effects. The United States Food and Drug Administration
(FDA) cautions against prescription of antipsychotics to
elderly persons, due to the increased risk of cardiovascular
mortality resulting from chronic use (Qato et al., 2008).
Aspirin and clopidogrel were the least prescribed medications.
The potential, serious side effects on the elderly include gas-
trointestinal upsets, gastric bleeding and bleeding disorders.
The most common PIMs in our study were antipsychotics, tri-
cyclic antidepressants, anticholinergics/muscle relaxants/
antispasmodics, antiepileptics, sedative-hypnotics, antihyper-
tensive, skeletal muscle relaxants, anti-infectives, oral hypogly-
caemics, analgesics and opioids, platelet aggregation-
inhibitors, antiarrhythmics, and iron supplements.
The possibility of an ADE should always be considered
when evaluating elderly patients; any new symptom should
be considered drug-related, until proven otherwise. Pharma-
cokinetic changes lead to increased plasma drug concentra-
tions, and pharmacodynamic changes to increased drug
sensitivity in older adults (Avorn et al., 1989). Various criteria
have been introduced for identifying medications to avoid pre-
scribing, or to prescribe cautiously, in older adults. Compli-
ance with these is suboptimal. Clinicians could address this
by avoiding overly prescribing inappropriate drug therapies.
ADEs result in four times as many hospitalisations in elderly
patients as in younger adults (AGSP, 2009). Prescription of
cascades, drug–drug interactions and inappropriate drug doses
result in preventable ADEs. Prescription of PIMs, as shown in
this study, is a concern for elderly patients attending outpa-
tient clinics and home residents; atypical antipsychotics, iron
overdose, benzodiazepines and opioids are most commonly
prescribed inappropriately. A step-wise approach towards pre-
scriptions for older adults should include periodic review of
current drug therapy; discontinuation of unnecessary medica-
tions; consideration of non-pharmacologic alternative strate-
gies; consideration of safer, alternative medications; and
prescription of the lowest possible effective dose and necessary
beneficial medications only.References
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